Patent: 10,751,372
✉ Email this page to a colleague
Summary for Patent: 10,751,372
| Title: | Vaccine compositions and methods |
| Abstract: | The present invention relates to pharmaceutical vaccine compositions comprising at least one vaccine antigen together with living immune cells. These immune cells include at least a portion of activated T-cells and act as an adjuvant. Methods for using these pharmaceutical compositions to prevent or treat diseases, such as cancer, infectious diseases and autoimmune disease are also included. |
| Inventor(s): | Michael Har-Noy |
| Assignee: | Mirror Biologics Inc |
| Application Number: | US16/215,116 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,751,372
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | STRENSIQ | asfotase alfa | Injection | 125513 | 23-Oct-15 | 10,751,372 | 2038-12-10 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,751,372
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2009242471 | ⤷ Start Trial |
| Australia | 2011240752 | ⤷ Start Trial |
| Australia | 2016231642 | ⤷ Start Trial |
| Australia | 2018204834 | ⤷ Start Trial |
| Brazil | 112012026007 | ⤷ Start Trial |
| Canada | 2726007 | ⤷ Start Trial |
| Canada | 2739255 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
